Category 1
Enterprise research platforms
~$24k–$60k+ / seat / year
AlphaSense · Hebbia · Kensho · Calcbench · Intelligize+
Vast document corpora — filings, transcripts, broker research, expert calls — with search and
agents over the top. AlphaSense reached roughly $600M ARR and a $7.5B valuation in 2026 and
closed the $930M Tegus acquisition; Hebbia sells to asset managers, investment banks and
Fortune 500 finance teams.
Buy this ifYou have a research budget, need broker notes and transcripts alongside filings, and a seat pays for itself in one deal.
It won't help withWatching a competitor's pricing page. These are built for investors and bankers, not for the person who owns a price list.
Category 2
Competitive intelligence suites
~$15k–$40k / year · newer entrants from €59/mo
Crayon · Klue · Kompyte · Contify · IndustryLens · Parano · Valona
Crawl competitor websites, pricing pages, job boards, review sites and news; a product
marketer curates; the result lands in battlecards inside Salesforce or Slack. Crayon is built
collection-first, Klue distribution-first. The AI-native newcomers publish real method notes —
IndustryLens publishes at €59 a month, monitors 350+ sources and attaches evidence to every insight; Parano runs €89–€299 and covers marketing, pricing, reviews, hires and funding on autopilot.
Buy this ifYou have reps losing deals to competitors and need battlecards where they already work. Nothing here replaces that.
It won't help withAnything a company disclosed in a filing rather than published on a website. That's a different corpus entirely.
Category 3
Price and page monitors
Free tiers · from ~$1.20 per 1,000 pages
PageCrawl · PricePulse · Verid · Visualping · Apify actors
Point them at a URL, get an alert when it changes. Capterra lists 67 products in this category
alone. They are cheap, they work, and several have free plans.
Buy this ifYou only need to know that a page changed. Genuinely solved, at close to zero cost.
It won't help withTelling you whether the change mattered, or what the same company told the SEC about how it's going.
Where this fits
Day91
Free — in beta
Eight tools · four standing resources · an MCP endpoint · a weekly brief
The narrow thing none of the three does: reading a company's own filings against
itself, and grading how good the sourcing is. Category 1 has the corpus but sells to
investors. Category 2 reads websites, not filings. Category 3 sees that a number changed but
not what it means. Day91 sits on the seam — filings plus live pricing pages, one buyer, every
claim marked A, B or C.
As of v3 the filings side runs on structured XBRL rather than on prose. Every figure a filer
tagged is kept as a series with the accession number it came from, which makes four checks
arithmetic rather than interpretive: a period filed twice with two different values, a
disclosure that stopped, two measures that normally move together moving apart, and a
reversal against a company's own trend. A restatement found this way is not a model output
and not a judgement — it is the company's own number, revised, with both submissions linked.
The reason the rest still shows its working is measurable. The Fin-RATE benchmark from
Goldman Sachs and Yale found model accuracy dropping roughly 18.6% on tracking one company's
filings over time and 14.35% on comparing across companies. Those are the two tasks that
produce edge. The v3 answer is to do the provable part with arithmetic and leave the
interpretive part visibly heuristic, rather than to blend the two and present the result as
one confident output.
Use this ifYou need to know what a competitor disclosed, whether it contradicts what they disclosed last quarter, and what they quietly did to their price — with the document attached.
Don't use this ifYou need battlecards in Salesforce, transcripts and broker research, or coverage of more than a handful of companies today.